Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000921895-17-000445
Filing Date
2017-02-21
Accepted
2017-02-21 16:00:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 THE SCHEDULE 13D sc13d06922001_02212017.htm SC 13D 92935
  Complete submission text file 0000921895-17-000445.txt   94314
Mailing Address 611 SOUTH FORT HARRISON AVE SUITE 306 CLEARWATER FL 33756
Business Address
DUGGAN ROBERT W (Filed by) CIK: 0001055919 (see all company filings)

Type: SC 13D

Mailing Address 849 MITTEN ROAD SUITE 104 BURLINGAME CA 94010
Business Address 849 MITTEN ROAD SUITE 104 BURLINGAME CA 94010 650-697-3939
Pulse Biosciences, Inc. (Subject) CIK: 0001625101 (see all company filings)

EIN.: 465696597 | State of Incorp.: NV | Fiscal Year End: 1217
Type: SC 13D | Act: 34 | File No.: 005-89516 | Film No.: 17625006
SIC: 3841 Surgical & Medical Instruments & Apparatus